198 related articles for article (PubMed ID: 27251775)
21. Regioselective C-H hydroxylation of omeprazole sulfide by Bacillus megaterium CYP102A1 to produce a human metabolite.
Jang HH; Ryu SH; Le TK; Doan TT; Nguyen TH; Park KD; Yim DE; Kim DH; Kang CK; Ahn T; Kang HS; Yun CH
Biotechnol Lett; 2017 Jan; 39(1):105-112. PubMed ID: 27640009
[TBL] [Abstract][Full Text] [Related]
22. Regioselective hydroxylation of C(12)-C(15) fatty acids with fluorinated substituents by cytochrome P450 BM3.
Chiang CH; Ramu R; Tu YJ; Yang CL; Ng KY; Luo WI; Chen CH; Lu YY; Liu CL; Yu SS
Chemistry; 2013 Oct; 19(41):13680-91. PubMed ID: 24092541
[TBL] [Abstract][Full Text] [Related]
23. Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes.
Weber E; Seifert A; Antonovici M; Geinitz C; Pleiss J; Urlacher VB
Chem Commun (Camb); 2011 Jan; 47(3):944-6. PubMed ID: 21079837
[TBL] [Abstract][Full Text] [Related]
24. The role of the conserved threonine in P450 BM3 oxygen activation: substrate-determined hydroxylation activity of the Thr268Ala mutant.
Cryle MJ; De Voss JJ
Chembiochem; 2008 Jan; 9(2):261-6. PubMed ID: 18161730
[TBL] [Abstract][Full Text] [Related]
25. An efficient route to selective bio-oxidation catalysts: an iterative approach comprising modeling, diversification, and screening, based on CYP102A1.
Seifert A; Antonovici M; Hauer B; Pleiss J
Chembiochem; 2011 Jun; 12(9):1346-51. PubMed ID: 21591046
[TBL] [Abstract][Full Text] [Related]
26. The full-length cytochrome P450 enzyme CYP102A1 dimerizes at its reductase domains and has flexible heme domains for efficient catalysis.
Zhang H; Yokom AL; Cheng S; Su M; Hollenberg PF; Southworth DR; Osawa Y
J Biol Chem; 2018 May; 293(20):7727-7736. PubMed ID: 29618513
[TBL] [Abstract][Full Text] [Related]
27. Rational re-design of the substrate binding site of flavocytochrome P450 BM3.
Ost TW; Miles CS; Murdoch J; Cheung Y; Reid GA; Chapman SK; Munro AW
FEBS Lett; 2000 Dec; 486(2):173-7. PubMed ID: 11113461
[TBL] [Abstract][Full Text] [Related]
28. Engineering cytochrome P450 BM3 of Bacillus megaterium for terminal oxidation of palmitic acid.
Brühlmann F; Fourage L; Ullmann C; Haefliger OP; Jeckelmann N; Dubois C; Wahler D
J Biotechnol; 2014 Aug; 184():17-26. PubMed ID: 24833423
[TBL] [Abstract][Full Text] [Related]
29. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
Murataliev MB; Klein M; Fulco A; Feyereisen R
Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
[TBL] [Abstract][Full Text] [Related]
30. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
31. Cytochrome P450 catalyzed oxidative hydroxylation of achiral organic compounds with simultaneous creation of two chirality centers in a single C-H activation step.
Roiban GD; Agudo R; Reetz MT
Angew Chem Int Ed Engl; 2014 Aug; 53(33):8659-63. PubMed ID: 24590553
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of ω-hydroxy dodecanoic acid based on an engineered CYP153A fusion construct.
Scheps D; Honda Malca S; Richter SM; Marisch K; Nestl BM; Hauer B
Microb Biotechnol; 2013 Nov; 6(6):694-707. PubMed ID: 23941649
[TBL] [Abstract][Full Text] [Related]
33. Whole-cell microtiter plate screening assay for terminal hydroxylation of fatty acids by P450s.
Weissenborn MJ; Notonier S; Lang SL; Otte KB; Herter S; Turner NJ; Flitsch SL; Hauer B
Chem Commun (Camb); 2016 May; 52(36):6158-61. PubMed ID: 27074906
[TBL] [Abstract][Full Text] [Related]
34. Characterization of Two Self-Sufficient Monooxygenases, CYP102A15 and CYP102A170, as Long-Chain Fatty Acid Hydroxylases.
Rimal H; Lee WH; Kim KH; Park H; Oh TJ
J Microbiol Biotechnol; 2019 May; 30(5):777-784. PubMed ID: 32482945
[TBL] [Abstract][Full Text] [Related]
35. An Enzymatic Route to α-Tocopherol Synthons: Aromatic Hydroxylation of Pseudocumene and Mesitylene with P450 BM3.
Dennig A; Weingartner AM; Kardashliev T; Müller CA; Tassano E; Schürmann M; Ruff AJ; Schwaneberg U
Chemistry; 2017 Dec; 23(71):17981-17991. PubMed ID: 28990705
[TBL] [Abstract][Full Text] [Related]
36. Altering the regioselectivity of the subterminal fatty acid hydroxylase P450 BM-3 towards gamma- and delta-positions.
Dietrich M; Do TA; Schmid RD; Pleiss J; Urlacher VB
J Biotechnol; 2009 Jan; 139(1):115-7. PubMed ID: 18984016
[TBL] [Abstract][Full Text] [Related]
37. Construction of a thermostable cytochrome P450 chimera derived from self-sufficient mesophilic parents.
Eiben S; Bartelmäs H; Urlacher VB
Appl Microbiol Biotechnol; 2007 Jul; 75(5):1055-61. PubMed ID: 17468867
[TBL] [Abstract][Full Text] [Related]
38. Regio- and enantioselective alkane hydroxylation with engineered cytochromes P450 BM-3.
Peters MW; Meinhold P; Glieder A; Arnold FH
J Am Chem Soc; 2003 Nov; 125(44):13442-50. PubMed ID: 14583039
[TBL] [Abstract][Full Text] [Related]
39. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.
Venkataraman H; Verkade-Vreeker MC; Capoferri L; Geerke DP; Vermeulen NP; Commandeur JN
Bioorg Med Chem; 2014 Oct; 22(20):5613-20. PubMed ID: 24999003
[TBL] [Abstract][Full Text] [Related]
40. Engineered P450 BM3 and cpADH5 coupled cascade reaction for β-oxo fatty acid methyl ester production in whole cells.
Ensari Y; de Almeida Santos G; Ruff AJ; Schwaneberg U
Enzyme Microb Technol; 2020 Aug; 138():109555. PubMed ID: 32527525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
